Condition: Preleukemia · Myelodysplastic Neoplasm · Cytopenia · Sponsor: Kirsten Grønbæk
This is a single-arm pilot study of the feasibility and safety of metformin in patients with clonal cytopenia of undetermined significance (CCUS) or lower-risk myelodysplastic neoplasms (LR-MDS).
This description comes directly from the study's public registry record.
Kirsten Grønbæk, Professor, MD · +45 35456060 · Kirsten.Groenbaek@regionh.dk
Stine Ulrik Mikkelsen, MD · +45 35456071 · stine.ulrik.mikkelsen@regionh.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Copenhagen N, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04741945